vs
GREIF, INC（GEF）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
GREIF, INC的季度营收约是Revvity的1.3倍（$994.8M vs $772.1M），GREIF, INC净利率更高（17.6% vs 12.7%，领先4.8%），Revvity同比增速更快（5.9% vs -21.4%），过去两年Revvity的营收复合增速更高（9.0% vs -9.2%）
格瑞夫公司是全球工业包装产品及服务领域的领先企业，总部位于美国俄亥俄州特拉华市。公司最初以制桶业务起家，目前核心产品涵盖钢桶、纤维桶、塑料桶、中型散装容器、油桶、塑料瓶、密封件、箱板纸、瓦楞制品及粘合剂等，2018年位列《财富》美国1000强第617位。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
GEF vs RVTY — 直观对比
营收规模更大
GEF
是对方的1.3倍
$772.1M
营收增速更快
RVTY
高出27.3%
-21.4%
净利率更高
GEF
高出4.8%
12.7%
两年增速更快
RVTY
近两年复合增速
-9.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $994.8M | $772.1M |
| 净利润 | $174.6M | $98.4M |
| 毛利率 | 20.4% | — |
| 营业利润率 | 25.8% | 14.5% |
| 净利率 | 17.6% | 12.7% |
| 营收同比 | -21.4% | 5.9% |
| 净利润同比 | 1930.2% | 3.9% |
| 每股收益（稀释后） | — | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GEFRVTY
| Q4 25 | $994.8M | $772.1M | ||
| Q3 25 | $1.1B | $698.9M | ||
| Q2 25 | $1.4B | $720.3M | ||
| Q1 25 | $1.3B | $664.8M | ||
| Q4 24 | $1.4B | $729.4M | ||
| Q3 24 | $1.5B | $684.0M | ||
| Q2 24 | $1.4B | $691.7M | ||
| Q1 24 | $1.2B | $649.9M |
净利润GEFRVTY
| Q4 25 | $174.6M | $98.4M | ||
| Q3 25 | $64.0M | $46.7M | ||
| Q2 25 | $47.3M | $53.9M | ||
| Q1 25 | $8.6M | $42.2M | ||
| Q4 24 | $70.1M | $94.6M | ||
| Q3 24 | $87.1M | $94.4M | ||
| Q2 24 | $44.4M | $55.4M | ||
| Q1 24 | $67.2M | $26.0M |
毛利率GEFRVTY
| Q4 25 | 20.4% | — | ||
| Q3 25 | 22.7% | 53.6% | ||
| Q2 25 | 23.1% | 54.5% | ||
| Q1 25 | 19.4% | 56.5% | ||
| Q4 24 | 20.4% | — | ||
| Q3 24 | 20.0% | 56.3% | ||
| Q2 24 | 19.7% | 55.7% | ||
| Q1 24 | 18.4% | 54.6% |
营业利润率GEFRVTY
| Q4 25 | 25.8% | 14.5% | ||
| Q3 25 | 6.4% | 11.7% | ||
| Q2 25 | 8.6% | 12.6% | ||
| Q1 25 | 4.7% | 10.9% | ||
| Q4 24 | 8.9% | 16.3% | ||
| Q3 24 | 11.8% | 14.3% | ||
| Q2 24 | 7.2% | 12.4% | ||
| Q1 24 | 5.7% | 6.8% |
净利率GEFRVTY
| Q4 25 | 17.6% | 12.7% | ||
| Q3 25 | 5.6% | 6.7% | ||
| Q2 25 | 3.4% | 7.5% | ||
| Q1 25 | 0.7% | 6.4% | ||
| Q4 24 | 4.9% | 13.0% | ||
| Q3 24 | 6.0% | 13.8% | ||
| Q2 24 | 3.2% | 8.0% | ||
| Q1 24 | 5.6% | 4.0% |
每股收益（稀释后）GEFRVTY
| Q4 25 | — | $0.86 | ||
| Q3 25 | — | $0.40 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | — | $0.77 | ||
| Q3 24 | — | $0.77 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | — | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $243.5M | $919.9M |
| 总债务越低越好 | $655.1M | — |
| 股东权益账面价值 | $2.9B | $7.3B |
| 总资产 | $5.5B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.22× | — |
8季度趋势，按日历期对齐
现金及短期投资GEFRVTY
| Q4 25 | $243.5M | $919.9M | ||
| Q3 25 | $285.2M | $931.4M | ||
| Q2 25 | $252.7M | $991.8M | ||
| Q1 25 | $201.1M | $1.1B | ||
| Q4 24 | $197.7M | $1.2B | ||
| Q3 24 | $194.2M | $1.2B | ||
| Q2 24 | $196.0M | $2.0B | ||
| Q1 24 | $179.3M | $1.7B |
总债务GEFRVTY
| Q4 25 | $655.1M | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.4B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | $2.9B | — | ||
| Q2 24 | $2.9B | — | ||
| Q1 24 | $2.3B | — |
股东权益GEFRVTY
| Q4 25 | $2.9B | $7.3B | ||
| Q3 25 | $2.2B | $7.4B | ||
| Q2 25 | $2.1B | $7.6B | ||
| Q1 25 | $2.0B | $7.6B | ||
| Q4 24 | $2.1B | $7.7B | ||
| Q3 24 | $2.1B | $7.9B | ||
| Q2 24 | $2.0B | $7.9B | ||
| Q1 24 | $2.0B | $7.8B |
总资产GEFRVTY
| Q4 25 | $5.5B | $12.2B | ||
| Q3 25 | $6.7B | $12.1B | ||
| Q2 25 | $6.8B | $12.4B | ||
| Q1 25 | $6.6B | $12.4B | ||
| Q4 24 | $6.6B | $12.4B | ||
| Q3 24 | $6.8B | $12.8B | ||
| Q2 24 | $6.8B | $13.4B | ||
| Q1 24 | $6.0B | $13.4B |
负债/权益比GEFRVTY
| Q4 25 | 0.22× | — | ||
| Q3 25 | 1.06× | — | ||
| Q2 25 | 1.12× | — | ||
| Q1 25 | 1.24× | — | ||
| Q4 24 | 1.31× | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 1.44× | — | ||
| Q1 24 | 1.15× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-24.4M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | -0.14× | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流GEFRVTY
| Q4 25 | $-24.4M | $182.0M | ||
| Q3 25 | $197.7M | $138.5M | ||
| Q2 25 | $136.4M | $134.3M | ||
| Q1 25 | $-30.8M | $128.2M | ||
| Q4 24 | $187.2M | $174.2M | ||
| Q3 24 | $76.8M | $147.9M | ||
| Q2 24 | $87.5M | $158.6M | ||
| Q1 24 | $4.5M | $147.6M |
自由现金流GEFRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | — | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率GEFRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | — | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度GEFRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率GEFRVTY
| Q4 25 | -0.14× | 1.85× | ||
| Q3 25 | 3.09× | 2.97× | ||
| Q2 25 | 2.88× | 2.49× | ||
| Q1 25 | -3.58× | 3.03× | ||
| Q4 24 | 2.67× | 1.84× | ||
| Q3 24 | 0.88× | 1.57× | ||
| Q2 24 | 1.97× | 2.87× | ||
| Q1 24 | 0.07× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GEF
| Other | $501.0M | 50% |
| Sustainable Fiber Solutions Segment | $300.4M | 30% |
| Customized Polymer Solutions Segment | $124.8M | 13% |
| Durable Metal Solutions Segment | $62.5M | 6% |
| Innovative Closure Solutions Segment | $6.1M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
